Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV263
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,244
Award facts
- Contract value 100% obligated
- $10,243.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,243.77 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 ml pen injection units. The contract was awarded on January 6, 2026, with an ultimate completion date of January 7, 2026, and utilizes firm fixed-price pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp functions as a critical vendor in the federal pharmaceutical supply chain, specializing in the distribution of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Wegovy order supports the Defense Logistics Agency's medical supply operations serving military treatment facilities and other federal healthcare systems. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its capability to compete successfully in open competition for diverse pharmaceutical procurement needs, with historical contract values ranging significantly in scope and supporting various therapeutic areas including diabetes management, neurological treatments, and pain management.
Quick answers
Who was awarded contract SPE2DR26FV263?
SPE2DR26FV263 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FV263 worth?
The government has obligated $10,244 on SPE2DR26FV263.
Is contract SPE2DR26FV263 an order under another contract?
Yes. SPE2DR26FV263 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV263 competed?
The extent of competition for SPE2DR26FV263 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award